kidney stones and glp-1 The boom in GLP1 drugs is actually changing our food supply the nutrition marketing messages we hear.⁠, ⁠, The "more protein" message certainly seems at odds with general stone advice. Effect of GLP-1 RA Use

In Phase 1 studies, survodutide was generally well tolerated, with no significant safety or tolerability issues observed in either healthy individuals with overweight or obesity [87, 88]

There are definitely ways to mitigate these symptoms, though, and, at the end of the day, most people would rather deal with some minor inconveniences if they were able to lose 50+ pounds or more of weight, but these symptoms are still troublesome

These medications can be prescribed by a licensed clinicianobesity specialist, general practitioner (MD, DO), endocrinologist, nurse practitioner, or physician assistantwhether in person or online

Cholesterol: 15mg

Patients on specific diabetes or thyroid medications should confirm safety with their provider